Although the two-transmembrane-domain tertiary structure of RTN3 and RTN4 seems to critically affect BACE1 enzymatic activity (Kume et al. 2009a, b), the relevance of these RTNs for AD pathology and their exact role remains controversial and thus yet to be established. This evidence concerns the gene BACE1 and Alzheimer disease.